The median age in this study (44 years) and the predominance of female participants (60.8%) are consistent with patterns observed in prior research
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
Obesity is a known risk factor for kidney stones, and the weight loss associated with semaglutide might lower this risk
This is the timeframe from the Finkley study (improved laxity, firmness, wrinkle depth) and the Carey/Pickart ultrasound study (28% average collagen density increase)
In TRIUMPH-1, people taking retatrutide 12mg lost an average of 28.3% of their starting body weight at 80 weeks
Monthly GLP-1 programs in Little Rock start around $499